תוצאות חיפוש - Derek Wallace

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study

    Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, contro... מאת Vianney Tricou, Brandon Essink, John Ervin, M. Turner, Ian Escudero, Martina Rauscher, Manja Brose, Inge Lefevre, Astrid Borkowski, Derek Wallace

    יצא לאור 2023
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  2. 2
    Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue

    Effect of the Tetravalent Dengue Vaccine TAK-003 on Sequential Episodes of Symptomatic Dengue מאת Xavier Sáez‐Llorens, Shibadas Biswal, Charissa Borja-Tabora, LakKumar Fernando, Mengya Liu, Derek Wallace, Nicolas Folschweiller, Humberto Reynales, Inge Lefevre, _ _

    יצא לאור 2023
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  3. 3
    Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study

    Safety and immunogenicity of different doses and schedules of a live attenuated tetravalent dengue vaccine (TDV) in healthy adults: A Phase 1b randomized study מאת Richard Rupp, Gary J. Luckasen, Judith L. Kirstein, Jorge E. Osorio, Joseph D. Santangelo, Marsha G. Raanan, Mary Smith, Derek Wallace, Gilad S. Gordon, Dan T. Stinchcomb

    יצא לאור 2015
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  4. 4
    A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus vaccine in a dengue non-endemic country

    A randomized phase 3 trial of the immunogenicity and safety of coadministration of a live-attenuated tetravalent dengue vaccine (TAK-003) and an inactivated hepatitis a (HAV) virus... מאת Vianney Tricou, Susannah Eyre, Mahadev Ramjee, Paul Collini, Zenaida Reynoso Mojares, Edde Loeliger, Sanja Mandarić, Martina Rauscher, Manja Brose, Inge Lefevre, Nicolas Folschweiller, Derek Wallace

    יצא לאור 2023
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  5. 5
    Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, controlled trial

    Safety and immunogenicity of a single dose of a tetravalent dengue vaccine with two different serotype-2 potencies in adults in Singapore: A phase 2, double-blind, randomised, cont... מאת Vianney Tricou, Jenny G. Low, Helen Oh, Yee‐Sin Leo, Shirin Kalimuddin, Limin Wijaya, Junxiong Pang, Li Min Ling, Tau Hong Lee, Manja Brose, Yanee Hutagalung, Martina Rauscher, Astrid Borkowski, Derek Wallace

    יצא לאור 2019
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  6. 6
    Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study

    Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Healthy Children and Adults in Dengue-Endemic Regions: A Randomized, Placebo-Controlled Phase 2 Study מאת Chukiat Sirivichayakul, Elizabeth A Barranco-Santana, Inés Esquilin-Rivera, Helen Oh, Marsha G. Raanan, Carlos A. Sariol, Lynette Pei‐Chi Shek, Sriluck Simasathien, Mary Smith, Iván Darío Vélez, Derek Wallace, Gilad S. Gordon, Dan T. Stinchcomb

    יצא לאור 2015
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  7. 7
    Development of standard clinical endpoints for use in dengue interventional trials: introduction and methodology

    Development of standard clinical endpoints for use in dengue interventional trials: introduction and methodology מאת Thomas Jaenisch, Kim Hendrickx, Martin Erpicum, Liane Agulto, Kay M. Tomashek, Walla Dempsey, João Bosco Siqueira, Morgan A. Marks, Michael P. Fay, Catherine Laughlin, Maïna L’Azou, Yee‐Sin Leo, Federico Narvaez, R Teyssou, Stephen J. Thomas, Hasitha Tissera, Derek Wallace, Annelies Wilder‐Smith, Duane J. Gubler, M. Cristina Cassetti

    יצא לאור 2018
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  8. 8
    Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents

    Efficacy of a Tetravalent Dengue Vaccine in Healthy Children and Adolescents מאת Shibadas Biswal, Humberto Reynales, Xavier Sáez‐Llorens, Pío López, Charissa Borja-Tabora, Pope Kosalaraksa, Chukiat Sirivichayakul, Veerachai Watanaveeradej, Luis Rivera, Félix Espinoza, LakKumar Fernando, Reynaldo Dietze, Kléber Giovanni Luz, Rivaldo Venâncio da Cunha, José Jimeno, Eduardo López-Medina, Astrid Borkowski, Manja Brose, Martina Rauscher, Inge Lefevre, Svetlana Bizjajeva, Lulu Bravo, Derek Wallace

    יצא לאור 2019
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  9. 9
    Development of standard clinical endpoints for use in dengue interventional trials

    Development of standard clinical endpoints for use in dengue interventional trials מאת Kay M. Tomashek, Bridget Wills, Lucy Chai See Lum, Laurent Thomas, Anna P. Durbin, Yee‐Sin Leo, Norma de Bosch, Elsa Rojas, Kim Hendrickx, Martin Erpicum, Liane Agulto, Thomas Jaenisch, Hasitha Tissera, Piyarat Suntarattiwong, Beth Ann Collers, Derek Wallace, Alexander C. Schmidt, Alexander Roberto Precioso, Federico Narvaez, Stephen J. Thomas, Robert Edelman, João Bosco Siqueira, M. Cristina Cassetti, Walla Dempsey, Duane J. Gubler

    יצא לאור 2018
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  10. 10
    Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003)

    Three-year Efficacy and Safety of Takeda’s Dengue Vaccine Candidate (TAK-003) מאת Luis Rivera, Shibadas Biswal, Xavier Sáez‐Llorens, Humberto Reynales, Eduardo López‐Medina, Charissa Borja-Tabora, Lulu Bravo, Chukiat Sirivichayakul, Pope Kosalaraksa, Luis Martinez Vargas, Delia Yu, Veerachai Watanaveeradej, Félix Espinoza, Reynaldo Dietze, LakKumar Fernando, Pujitha Wickramasinghe, Edson Duarte Moreira, Asvini D. Fernando, Dulanie Gunasekera, Kléber Giovanni Luz, Rivaldo Venâncioda Cunha, Martina Rauscher, Olaf Zent, Mengya Liu, Elaine Hoffman, Inge Lefevre, Vianney Tricou, Derek Wallace, MariaTheresa Alera, Astrid Borkowski

    יצא לאור 2021
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  11. 11
    Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination

    Efficacy of a Dengue Vaccine Candidate (TAK-003) in Healthy Children and Adolescents 2 Years after Vaccination מאת Eduardo López‐Medina, Shibadas Biswal, Xavier Sáez‐Llorens, Charissa Borja-Tabora, Lulu Bravo, Chukiat Sirivichayakul, Luis Martinez Vargas, Maria Theresa Alera, Hector Velásquez, Humberto Reynales, Luis Rivera, Veerachai Watanaveeradej, Edith Johana Rodriguez-Arenales, Delia Yu, Félix Espinoza, Reynaldo Dietze, Lak Kumar Fernando, Pujitha Wickramasinghe, Edson Duarte Moreira, Asvini D. Fernando, Dulanie Gunasekera, Kléber Giovanni Luz, Rivaldo Venâncio da Cunha, Vianney Tricou, Martina Rauscher, Mengya Liu, Inge Lefevre, Derek Wallace, Pope Kosalaraksa, Astrid Borkowski

    יצא לאור 2020
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  12. 12
    Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial

    Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial מאת Vianney Tricou, Delia Yu, Humberto Reynales, Shibadas Biswal, Xavier Sáez‐Llorens, Chukiat Sirivichayakul, Pío López, Charissa Borja-Tabora, Lulu Bravo, Pope Kosalaraksa, Luis Martinez Vargas, Maria Theresa Alera, Luis Rivera, Veerachai Watanaveeradej, Reynaldo Dietze, LakKumar Fernando, Pujitha Wickramasinghe, Edson Duarte Moreira, Asvini D. Fernando, Dulanie Gunasekera, Kléber Giovanni Luz, Ana Oliveira, Suely Tuboi, Ian Escudero, Yanee Hutagalung, Eric Lloyd, Martina Rauscher, Olaf Zent, Nicolas Folschweiller, Inge Lefevre, Félix Espinoza, Derek Wallace

    יצא לאור 2024
    קבל טקסט מלא קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:
  13. 13
    Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination

    Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination מאת Chukiat Sirivichayakul, Shibadas Biswal, Xavier Sáez‐Llorens, Eduardo López‐Medina, Charissa Borja-Tabora, Lulu Bravo, Pope Kosalaraksa, Maria Theresa Alera, Humberto Reynales, Luis Rivera, Veerachai Watanaveeradej, Delia Yu, Félix Espinoza, Reynaldo Dietze, LakKumar Fernando, Pujitha Wickramasinghe, Edson Duarte Moreira, Asvini D. Fernando, Dulanie Gunasekera, Kléber Giovanni Luz, Rivaldo Venâncio da Cunha, Ana Oliveira, Martina Rauscher, Huihao Fan, Astrid Borkowski, Ian Escudero, Suely Tuboi, Eric Lloyd, Vianney Tricou, Nicolas Folschweiller, Inge Lefevre, Luis Martinez Vargas, Derek Wallace, Asvini D. Fernando, Charissa Borja-Tabora, Chukiat Sirivichayakul, Delia Yu, Dulanie Gunasekera, Eduardo López-Medina, Edith Johanna Rodriguez-Arenales, Edson Duarte Moreira, Félix Espinoza, Hector Velásquez, Humberto Reynales, Kléber Giovanni Luz, José Jimeno, LakKumar Fernando, Lulu Bravo, Luis Martinez Vargas, Luis Rivera, Maria Theresa Alera, Onanong Manacharoen, Pío López, Pope Kosalaraksa, Pujitha Wickramasinghe, Reynaldo Dietze, Rivaldo Venâncio da Cunha, Veerachai Watanaveeradej, Xavier Sáez‐Llorens, Manja Brose, Shibadas Biswal, Yanee Hutagalung, Suely Tuboi

    יצא לאור 2024
    קבל טקסט מלא
    Artigo
    הוספה למועדפים
    שמור ב:

כלי חיפוש: